Joseph Carreno

ID PharmD, Pharmacy Practice professor, karate student, salsa dancer and rock climber

[Joseph Carreno @jocarreno]

Vote!

[Joseph Carreno @jocarreno]

Happy Halloween!

[Joseph Carreno @jocarreno]

Friendship is the most important type of ship…followed closely by antimicrobial stewardship #antimicrobialstewardship #IDWEEK2024

[Albany College of Pharmacy and Health Sciences @acphsofficial]

Associate Professor Dr. Lauren Purington describes the effects of opioids on the brain in a new series from @WMHTPubMedia, "Opioids in NY: Stories and Solutions." Check out the series ⬇️ https://t.co/Ig4CnyVbdY

[Joseph Carreno @jocarreno]

So honored and humbled receive this award! Thank you to the @PharmacoJournal board for selecting me!

[Pharmacotherapy @PharmacoJournal]

Congratulations @jocarreno! https://t.co/f1Nhw1Se55 @acphsofficial #PeerReviewWeek

[Joseph Carreno @jocarreno]

🎉 Congrats to our exceptional @acphsofficial alum & BOT member on being elected as @ASHPOfficial President! Your leadership journey is inspiring, shaping pharmacy & patient care. Wishing you success! 👏 #ASHP #PharmacyLeadership #AlumniSuccess https://t.co/0XFrOiwaV4

[Joseph Carreno @jocarreno]

Informative, entertaining, and clinically relavent. A hard balance but host @ErinMcCreary and guests really hit the nail on the head! Strong work @SIDPharm Pubs and Pods 💊🎧

[SIDP @SIDPharm]

🆕 Episode of #Breakpoints! 🫁

Curious about controversies in the management of HAP/VAP? Let’s clear the air!

Check out this infographic from @littlebugdrug and @moore_wjustin and listen along as Drs. @dblake096, @owenralb, and Ryan Rivosecchi join @ErinMcCreary to discuss!

[Joseph Carreno @jocarreno]

Student success: one of the most rewarding aspects of being an educator. I am so proud of this @acphsofficial student-led publication evaluating the impact of geospatial factors on UTI. Available for free until 5/1/2023 https://t.co/7nDcBhklO7 #IDTwitter

[Joseph Carreno @jocarreno]

@julie_justo @IDPharmacometrx @Warren_E_Rose @emilylheil @IDpharmresearch @ErinMcCreary @IDPharmProf @Kerry_LaPlante @MikeMndudley @jpogue1 @ChrisRFrei @KellyReveles @erin_barreto @julie_justo honored to be considered in this fine group. #PharmacistScientist feels more inclusive in my opinion, although it looks like NIH already does consider PharmDs eligible for Clinician Scientist Awards

[Joseph Carreno @jocarreno]

@IDWeek2022 giving the people what they want!

[Kevin Nguyen @PharmD_Kev]

Publication and Podcast committee also the “most photogenic” committee 🔥🔥🔥
.
.
#IDweek #SIDP @SIDPharm

[Joseph Carreno @jocarreno]

My first trip since 2019 to @SIDPharm and @IDWeek2022 going to miss these two 🥺

[Joseph Carreno @jocarreno]

42 days later he’s fully vaxxed! Thank you science!!!

[Joseph Carreno @jocarreno]

@IDstewardship @Kickstarter @PharmageddonG @PharmacyPosts @KisgenUF @mmPharmD @ABsteward @ErinMcCreary @julie_justo @BRxAD @blandman19 @RSPugliese @SIDPharm @SIDPharm should host a tournament at the next annual meeting

[Joseph Carreno @jocarreno]

When I first started in academia the best advice I ever got was when you think of how long it takes you to do a task multiply that time by 1.5 - 2x. My sister breaks down why that’s a great idea for projects https://t.co/7f2RzhJgF5

[Joseph Carreno @jocarreno]

@zkePharmD @julie_justo Right there with you @julie_justo

[Joseph Carreno @jocarreno]

@emilylheil Absolutely knocked it out of the park! Congratulations!

[NEJM @NEJM]

In this editorial, Emily L. Heil, Pharm.D., and Shyam Kottilil, M.D., Ph.D., provide insight on Gottlieb et al.'s clinical trial of early outpatient remdesivir treatment to prevent progression to severe #COVID19. https://t.co/DfSuRj2Ba7

[Joseph Carreno @jocarreno]

C. auris amphotericin B mechanism elucidated for the first time. These data will be critically important to helping identify new therapeutic modalities for this urgent threat. Strong work @Rybak_JM !

[Jeffrey M. Rybak PharmD, PhD @Rybak_JM]

Now in print at CMI: we identify the first mechanism of clinical amphotericin B resistance in C. auris; in vivo acquired mutations in ERG6 confer high-level amphotericin B resistance. @StJudeResearch https://t.co/vrWRMviet5